{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T14:45:06Z","timestamp":1766760306184,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T00:00:00Z","timestamp":1550707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00223-019-00536-x","type":"journal-article","created":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T10:36:10Z","timestamp":1550745370000},"page":"650-657","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A Comprehensive Study of Bone Manifestations in Adult Gaucher Disease Type 1 Patients in Argentina"],"prefix":"10.1007","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6694-4341","authenticated-orcid":false,"given":"Beatriz","family":"Oliveri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felisa","family":"Quiroga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Rozenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,21]]},"reference":[{"key":"536_CR1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3390\/ijms18020441","volume":"18","author":"J Stirnemann","year":"2017","unstructured":"Stirnemann J, Belmatoug N, Camou F, Serratrice C, Froissart R, Caillaud C et al (2017) A review of Gaucher disease pathophysiology, clinical presentation and treatments. Int J Mol Sci 18:441","journal-title":"Int J Mol Sci"},{"key":"536_CR2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.tips.2004.01.004","volume":"25","author":"AH Futerman","year":"2004","unstructured":"Futerman AH, Sussman JL, Horowitz M, Silman I, Zimran A (2004) New directions in the treatment of Gaucher disease. Trends Pharmacol Sci 25:147\u2013151","journal-title":"Trends Pharmacol Sci"},{"key":"536_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/humu.1380030102","volume":"3","author":"M Horowitz","year":"1994","unstructured":"Horowitz M, Zimran A (1994) Mutations causing Gaucher disease. Hum Mutat 3:1\u201311","journal-title":"Hum Mutat"},{"key":"536_CR4","first-page":"273","volume":"72","author":"G Drelichman","year":"2012","unstructured":"Drelichman G, Linares A, Villalobos J, Cabello JF, Kerstenetzky M, Kohan RM, Martins AM. (2012) Gaucher disease in Latin America. A report from the Gaucher Disease International Registry and the Latin American Group for Gaucher Disease. Medicina 72:273\u201382","journal-title":"Medicina"},{"key":"536_CR5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/MD.0b013e3182057be4","volume":"90","author":"PB Deegan","year":"2011","unstructured":"Deegan PB, Pavlova E, Tindall J et al (2011) Osseous manifestations of adult Gaucher disease in the era of enzyme replacement therapy. Medicine (Baltimore) 90:52\u201360","journal-title":"Medicine (Baltimore)"},{"key":"536_CR6","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00223-014-9923-y","volume":"95","author":"G Marcucci","year":"2014","unstructured":"Marcucci G, Zimran A, Bembi B et al (2014) Gaucher disease and bone manifestations. Calcif Tissue Int 95:477\u2013494","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"536_CR7","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s11136-004-0794-y","volume":"14","author":"P Giraldo","year":"2005","unstructured":"Giraldo P, Solano V, P\u00e9rez-Calvo JI, Giralt M, Rubio-F\u00e9lix D, Spanish Group on Gaucher disease (2005) Quality of life related to type 1 Gaucher disease: Spanish experience. Qual Life Res 14(2):453\u2013462","journal-title":"Qual Life Res"},{"issue":"1","key":"536_CR8","doi-asserted-by":"publisher","first-page":"A2","DOI":"10.1259\/bjr.75.suppl_1.750002","volume":"75","author":"RJ Wenstrup","year":"2002","unstructured":"Wenstrup RJ, Roca-Espiau M, Weinreb NJ, Bembi M (2002) Skeletal aspects of Gaucher disease: a review. Br J Radiol 75(1):A2\u2013A12","journal-title":"Br J Radiol"},{"key":"536_CR9","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","volume":"8","author":"HK Genant","year":"1993","unstructured":"Genant HK, Wu CY, van Kuijk C et al (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137\u20131148","journal-title":"J Bone Miner Res"},{"key":"536_CR10","unstructured":"https:\/\/www.iscd.org\/official-positions\/2nd-iscd-pediatric-position-development-conference\/"},{"key":"536_CR11","unstructured":"https:\/\/www.iscd.org\/official-positions\/6th-iscd-position-development-conference-adult"},{"key":"536_CR12","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/jbmr.2176","volume":"29","author":"BC Silva","year":"2014","unstructured":"Silva BC, Leslie D, Resch H et al (2014) Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res 29:518\u2013530","journal-title":"J Bone Miner Res"},{"issue":"2","key":"536_CR13","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1148\/radiol.2292020296","volume":"229","author":"M Maas","year":"2003","unstructured":"Maas M, van Kuijk C, Stoker J et al (2003) Quantification of bone involvement in Gaucher disease: MR imaging bone marrow burden score as an alternative to dixon quantitative chemical shift MR imaging\u2013initial experience. Radiology 229(2):554\u2013561","journal-title":"Radiology"},{"key":"536_CR14","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.bone.2017.07.020","volume":"103","author":"C Bondar","year":"2017","unstructured":"Bondar C, Mucci J, Crivaro A, Ormazabal M, Ceci R, Oliveri B, Gonz\u00e1lez D, Rozenfeld P (2017) In vitro osteoclastogenesis from Gaucher patients\u2019 cells correlates with bone mineral density but not with chitotriosidase. Bone 103:262\u2013269","journal-title":"Bone"},{"key":"536_CR15","first-page":"4","volume":"19","author":"G Drelichman","year":"2015","unstructured":"Drelichman G, Fern\u00e1ndez Escobar N, Basack N et al (2015) Argentina Gaucher disease consensus update: Argentine group for diagnosis and treatment of Gaucher disease. Hematologia 19:4\u201351","journal-title":"Hematologia"},{"key":"536_CR16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13023-014-0112-x","volume":"9","author":"L Dussen van","year":"2014","unstructured":"van Dussen L, Biegstraaten M, Dijkgraaf MGW, Hollak CEM (2014) Modelling Gaucher disease progression: long term enzyme replacement therapy reduces the incidence of splenectomy and bone complications. Orphanet J Rare Dis 9:112","journal-title":"Orphanet J Rare Dis"},{"key":"536_CR17","first-page":"126","volume":"68","author":"M Andrade-Campos","year":"2018","unstructured":"Andrade-Campos M, Valero E, Roca M, Giraldo P (2018) On behalf of the, Spanish group on Gaucher disease: the utility of magnetic resonance imaging for bone involvement in Gaucher disease. Assessing more than bone crises blood cells, Mol Dis 68: 126\u2013134","journal-title":"Mol Dis"},{"key":"536_CR18","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/archpedi.160.6.603","volume":"160","author":"P Kaplan","year":"2006","unstructured":"Kaplan P, Andersson HC, Kacena K, Yee JD (2006) The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis. Arch Pediatr Adolesc Med 160:603\u2013608","journal-title":"Arch Pediatr Adolesc Med"},{"key":"536_CR19","doi-asserted-by":"publisher","first-page":"E448","DOI":"10.1002\/ajh.24486","volume":"91","author":"G Drelichman","year":"2016","unstructured":"Drelichman G, Fern\u00e1ndez Escobar N, Basack N et al (2016) Skeletal involvement in Gaucher disease: an observational multicenter study of prognostic factors in the Argentine Gaucher disease patients. Am J Hematol 91:E448\u2013E453","journal-title":"Am J Hematol"},{"key":"536_CR20","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s10354-010-0841-y","volume":"160","author":"P Mikosch","year":"2010","unstructured":"Mikosch P, Hughes D (2010) An overview on bone manifestations in Gaucher disease. Wien Med Wochenschr 160:609\u2013624","journal-title":"Wien Med Wochenschr"},{"key":"536_CR21","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1002\/jbmr.1680","volume":"27","author":"A Khan","year":"2012","unstructured":"Khan A, Hangartner T, Weinreb NJ et al (2012) Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease: a study from the International Collaborative Gaucher Group (ICGG) Gaucher registry. J Bone Miner Res 27:1839\u20131848","journal-title":"J Bone Miner Res"},{"key":"536_CR22","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s001980050218","volume":"10","author":"LJ Melton","year":"1999","unstructured":"Melton LJ, Atkinson EJ, Cooper C, O\u00b4Fallon WM, Riggs BL (1999) Vertebral fractures predict subsequent fractures. Osteoporos Int 10:214\u2013221","journal-title":"Osteoporos Int"},{"key":"536_CR23","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/9781118453926.ch40","volume-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","author":"N Harvey","year":"2013","unstructured":"Harvey N, Dennison E, Cooper C (2013) The epidemiology of osteoporotic fractures. In: Rosen C (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, 8th edn. Wiley-Blackell, New Jersey, pp\u00a0348\u2013356","edition":"8"},{"key":"536_CR24","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1182\/blood-2009-04-210112","volume":"114","author":"S Crary","year":"2009","unstructured":"Crary S, Buchanan G (2009) Vascular complications after splenectomy for hematologic disorders. Blood 114:2861\u20132868","journal-title":"Blood"},{"key":"536_CR25","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/192761","author":"JM Mucci","year":"2015","unstructured":"Mucci JM, Rozenfeld P (2015) Pathogenesis of bone alterations in Gaucher disease: the role of immune system. J Immunol. \n                    https:\/\/doi.org\/10.1155\/2015\/192761","journal-title":"J Immunol"},{"issue":"9321","key":"536_CR26","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0140-6736(02)08761-5","volume":"359","author":"JA Kanis","year":"2002","unstructured":"Kanis JA (2002) Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359(9321):1929\u20131936","journal-title":"Lancet"},{"key":"536_CR27","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1002\/jbmr.499","volume":"26","author":"D Hans","year":"2011","unstructured":"Hans D, Goertzen AL, Krieg MA, Leslie WD (2011) Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study. J Bone Miner Res 26:2762\u20132769","journal-title":"J Bone Miner Res"},{"key":"536_CR28","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.bone.2015.05.016","volume":"78","author":"NC Harvey","year":"2015","unstructured":"Harvey NC, Gl\u00fcer CC, Binkley N, McCloskey EV, Brandi ML, Cooper C et al (2015) Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice: a consensus report of a European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) working group. Bone 78:216\u2013224. \n                    https:\/\/doi.org\/10.1016\/j.bone.2015.05.016","journal-title":"Bone"},{"key":"536_CR29","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s12020-014-0280-4","volume":"7","author":"FM Ulivieri","year":"2014","unstructured":"Ulivieri FM, Silva BC, Sardanelli F, Hans D, Bilezikian JP, Caudarella R (2014) Utility of the trabecular bone score (TBS) in secondary osteoporosis. Endocrine 7:435\u2013448","journal-title":"Endocrine"},{"key":"536_CR30","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.bcmd.2017.06.003","volume":"68","author":"M Baldini","year":"2018","unstructured":"Baldini M, Casirati G, Ulivieri FM, Cassinerio E, Chalouhi KK, Poggiali E et al (2018) Skeletal involvement in type 1 Gaucher disease: not just bone mineral density. Blood Cells Mol Dis 68:148\u2013152. \n                    https:\/\/doi.org\/10.1016\/j.bcmd.2017.06.003","journal-title":"Blood Cells Mol Dis"},{"key":"536_CR31","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1002\/jbmr.3121","volume":"32","author":"S Herrera","year":"2017","unstructured":"Herrera S, Perez-Lopez J, Molto-Abad M, Guerri-Fernandez G, Cabezudo E, Novelli S et al (2017) Assessment of bone health in patients with type 1 Gaucher disease using impact microindentation. J Bone Miner Res 32:1575\u20131581","journal-title":"J Bone Miner Res"},{"key":"536_CR32","first-page":"31","volume":"13","author":"MS Parisi","year":"2008","unstructured":"Parisi MS, Mastaglia SR, Bagur A, Goldstein G, Zeni SN, Oliveri B (2008) Body composition and bone metabolism in young Gaucher disease type I patients treated with imiglucerase. Eur J Med Res 13:31\u201338","journal-title":"Eur J Med Res"},{"key":"536_CR33","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1210\/jc.2011-0162","volume":"96","author":"L Dussen van","year":"2011","unstructured":"van Dussen L, Lips P, Everts VE et al (2011) Markers of bone turnover in Gaucher disease: modeling the evolution of bone disease. J Clin Endocrinol Metab 96:2194\u20132205","journal-title":"J Clin Endocrinol Metab"},{"key":"536_CR34","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.4081\/hr.2012.e21","volume":"4","author":"G Giuffrida","year":"2012","unstructured":"Giuffrida G, Cingari M, Parrinello N et al (2012) Bone turnover markers in patients with type 1 Gaucher disease. Hematol Rep 4:e21. \n                    https:\/\/doi.org\/10.4081\/hr.2012.e21","journal-title":"Hematol Rep"},{"key":"536_CR35","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1093\/hmg\/ddx442","volume":"27","author":"LM Panicker","year":"2018","unstructured":"Panicker LM, Srikanth MP, Castro-Gomes T, Miller D, Andrews NW. Feldman RA (2018) Gaucher disease iPSC-derived osteoblasts have developmental and lysosomal defects that impair bone matrix deposition. Hum Mol Genet 27:811\u2013822. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddx442","journal-title":"Hum Mol Genet"},{"key":"536_CR36","doi-asserted-by":"publisher","first-page":"19473","DOI":"10.1073\/pnas.1003308107","volume":"107","author":"PK Mistry","year":"2010","unstructured":"Mistry PK, Liu J, Yang M, Nottoli T, McGrath J, Jain D et al (2010) Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage. Proc Natl Acad Sci USA 107:19473\u201319478","journal-title":"Proc Natl Acad Sci USA"},{"key":"536_CR37","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.bcmd.2013.04.006","volume":"51","author":"M Reed","year":"2013","unstructured":"Reed M, Baker RJ, Mehta AB, Hughes D (2013) Enhanced differentiation of osteoclasts from mononuclear precursors in patients with Gaucher disease. Blood Cells Mol Dis 51:185\u2013194","journal-title":"Blood Cells Mol Dis"},{"key":"536_CR38","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.gene.2012.07.071","volume":"509","author":"M Mucci","year":"2012","unstructured":"Mucci M, Scian R, De Francesco PN et al (2012) Induction of osteoclastogenesis in an in vitro model of Gaucher disease is mediated by T cells via TNF-\u03b1. Gene 509:51\u201359. \n                    https:\/\/doi.org\/10.1016\/j.gene.2012.07.071","journal-title":"Gene"},{"key":"536_CR39","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bcmd.2016.11.004","volume":"68","author":"JKC Lai","year":"2018","unstructured":"Lai JKC, Robertson PL, Goh C, Szer J (2018) Intraobserver and interobserver variability of the bone marrow burden (BMB) score for the assessment of disease severity in Gaucher disease, possible impact of reporting experience. Blood Cell Mol Dis 68:121\u2013125","journal-title":"Blood Cell Mol Dis"},{"key":"536_CR40","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","volume":"22","author":"S Vasikaran","year":"2011","unstructured":"Vasikaran S, Eastell R, Bruyere O, Foldes AJ, Garnero P, Griesmacher A et al (2011) Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 22:391\u2013420. \n                    https:\/\/doi.org\/10.1007\/s00198-010-1501-1","journal-title":"Osteoporos Int"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-019-00536-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-019-00536-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-019-00536-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T19:24:27Z","timestamp":1582226667000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-019-00536-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,21]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["536"],"URL":"https:\/\/doi.org\/10.1007\/s00223-019-00536-x","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"type":"print","value":"0171-967X"},{"type":"electronic","value":"1432-0827"}],"subject":[],"published":{"date-parts":[[2019,2,21]]},"assertion":[{"value":"25 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Beatriz Oliveri, Diana Gonz\u00e1lez, and Paula Rozenfeld have received speaking honoraria from Shire; Felisa Quiroga and Claudio Silva declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethical Committee of IBYME (Instituto de Biolog\u00eda y Medicina Experimental, Argentina). All patients or their guardians provided written informed consent to participate in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}